RxDoctor Payments Data

Jeffrey Ho, MD

Clinical Cardiac Electrophysiology · Tacoma, WANPI 1265761951

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Siemens Medical Solutions USA, Inc. accounts for 64.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $2,753 and has fallen 64.8% since, to $969 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in WA, where the typical reported total is $7,912.

$8,407in general payments, 2019–2025

Across 52 payments — averaging $161.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$5K
  • Boston Scientific$1K
  • Biosense Webster, Inc.$964
  • Medtronic$534
  • Abbott$130
  • Amgen$42
  • plus $174 from 8 others

What the payments were for

  • Consulting fees$3,69544%
  • Speaking & faculty fees$1,70020%
  • Travel & lodging$6197%
  • Food & beverage$2,39228%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,407 in reported general payments places this provider in the 50th percentile of 68 clinical cardiac electrophysiology providers in Washington.

See all clinical cardiac electrophysiology providers in Washington

Medicare billing

Part B allowed, 2024
$438,072
Medicare patients
1,092
Services billed
6,210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban359$314,221
XareltoRivaroxaban77$69,542
Metoprolol Succinate331$4,643
Flecainide Acetate94$3,517
Amiodarone Hcl87$1,118
Colchicine72$1,010
SotalolSotalol Hcl102$945
ClopidogrelClopidogrel Bisulfate96$828
Diltiazem 24hr Er (Xr)Diltiazem Hcl37$780
Diltiazem 24hr Er (Cd)Diltiazem Hcl27$739
Atenolol11$479
Sucralfate76$466
Dilt-XrDiltiazem Hcl12$395
Pantoprazole Sodium71$323
Metoprolol Tartrate19$225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$14$69,54277 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 68 clinical cardiac electrophysiology providers in Washington.

Other clinical cardiac electrophysiology in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →